The study included 642 subjects with restrictive lung disease, characterized by a decrease in exhaled airflow, such as asthma, emphysema or bronchitis; 68 with obstructive lung disease, a decrease ...

Personalized care for patients with obstructive lung disease: uncover the ‘treatable traits’ concept and how it’s reshaping treatment strategies for better patient management.

Arexvy is currently approved to prevent lower respiratory tract disease (LRTD) caused by RSV in individuals aged 60 years and older, and those 50 to 59 years of age who are at increased risk for LRTD ...

Ochsner Baton Rouge welcomed several new providers, including Dr. Emilio Fabian Corona, a pulmonology and critical care medicine specialist who has joined Ochsner Health Center – Prairieville.

Referred to as ‘popcorn lung,’ the obstructive lung condition has been challenging clinicians for decades. But more recent outbreaks are helping to provide better clues for future patients.

COVID-19 can cause lasting lung damage: Three ways long COVID patients’ respiration can suffer "Long COVID" encompasses a slew of effects that lead to your body (and lungs) not functioning at ...

Aerwave Medical raised $12 million in a recently closed deal to advance a new therapy for chronic obstructive pulmonary disease, which completed its first human trials last week.

New research in Scientific Reports reveals that COVID-19 survivors, especially those who had severe or critical illness, face long-term lung complications and a reduced quality of life. The study ...

The lung tissue of people with chronic obstructive pulmonary disease contains triple the sootlike particle buildup found in similar tissue in smokers’ lungs, a recent analysis finds. The study ...

May 23, 2025 -- The FDA has approved the asthma drug Nucala for adults with chronic obstructive pulmonary disease (COPD).It is the second biologic therapy approved for the condition, following the ...